Farmak, the leader in the domestic pharmaceutical market, has expanded the Lamicon antifungal line with a new drug product, Lamicon Dermgel. The new drug is produced in the form of a gel (15 g).
Lamicon Dermgel is an antifungal agent in the form of a gel with a broad spectrum of action and a short course of treatment. It helps to eliminate one of the major symptoms of fungal skin infection – itching.
The drug is recommended for the treatment of skin infections caused by dermatophytes (tinea corporis, tinea cruris, tinea pedis) and tinea versicolor.
The main feature of the new drug is its cooling effect and antipruritic action.
Now the Lamicon antifungal portfolio has three dosage forms for topical use: Lamicon cream, Lamicon spray, Lamicon Dermgel, and also Lamicon in tablet form.
In total, the Fund donated over UAH 4 million to fight the COVID-19 pandemic in the Ruzhynskyi district, as well as to reconstruct and equip a first-aid post in Nemyryntsi village As part of the anti-pandemic campaign, the Zhebrivski Family Charitable Foundation provided the Municipal Non-Commercial Enterprise “District Central Hospital” of the Ruzhynskyi Di...
The video presents a story of a typical day of several Farmak employees who get up before dawn, take care of their loved ones and go to work to fulfil an important mission. In such a simple form, the director portrayed Farmak as the Company with a soul, where employees are ordinary people, with their […]
Due to the new manufacturing facility, the Company will increase the manufacturing of sterile liquid medicinal products, the demand for which has significantly grown during the pandemic. The new manufacturing facility is a seven-storey building with over 20 units of main technological equipment and about 100 engineering equipment. It was built from the groun...